Chemogenetic stimulation of the prefrontal cortex exerts antidepressant effect in a mouse model of depression
Maxime Veleanu, Stefan Vestring, Tsvetan Serchov, Claus Normann · FENS Forum 2024
The prefrontal cortex is one of the most commonly studied structures in depression. Synaptic loss and prefrontal circuits deficits have been widely described in depression physiopathology, and their restoration by antidepressant drugs is at the center of their therapeutic effect. Aims: This project aims to test the antidepressant potential of a specific manipulation of prefrontal circuits. Methods: Using the Chronic Despair Model (CDM) of depression, and the DREADDs chemogenetic technique, we counteracted the hypofrontality characteristic of a depressive-like state, and assessed the behavioura